NDRG4 | NDRG family member 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
NR5A1 | Nuclear receptor subfamily 5, group A, member 1 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NRIP3 | Nuclear receptor interacting protein 3 | Predicted intracellular proteins
| | | | | Group enriched |
RGN | Regucalcin | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
RIMS2 | Regulating synaptic membrane exocytosis 2 | Predicted intracellular proteins
| | | | | Group enriched |
SCARB1 | Scavenger receptor class B, member 1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SCG2 | Secretogranin II | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
TMEM179 | Transmembrane protein 179 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
TMEM196 | Transmembrane protein 196 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ZIM2 | Zinc finger, imprinted 2 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
CDH18 | Cadherin 18, type 2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CYP2W1 | Cytochrome P450, family 2, subfamily W, polypeptide 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
FAM43B | Family with sequence similarity 43, member B | Predicted intracellular proteins
| | | | | Group enriched |
GABRQ | Gamma-aminobutyric acid (GABA) A receptor, theta | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
GALNT13 | Polypeptide N-acetylgalactosaminyltransferase 13 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
GJD2 | Gap junction protein, delta 2, 36kDa | Predicted membrane proteins
| | | | | Tissue enriched |
GRIK1 | Glutamate receptor, ionotropic, kainate 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LUZP2 | Leucine zipper protein 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
LUZP6 | Leucine zipper protein 6 | Predicted intracellular proteins
| | | | | Group enriched |
MLXIPL | MLX interacting protein-like | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Group enriched |
NTRK1 | Neurotrophic tyrosine kinase, receptor, type 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
PEG10 | Paternally expressed 10 | Predicted intracellular proteins
| | | | | Group enriched |
RAPGEF4 | Rap guanine nucleotide exchange factor (GEF) 4 | Predicted intracellular proteins
| | | | | Group enriched |
SORBS2 | Sorbin and SH3 domain containing 2 | Predicted intracellular proteins
| | | | | Group enriched |
SRRM3 | Serine/arginine repetitive matrix 3 | Predicted intracellular proteins
| | | | | Group enriched |
TCEAL6 | Transcription elongation factor A (SII)-like 6 | Predicted intracellular proteins
| | | | | Group enriched |
UNC79 | Unc-79 homolog (C. elegans) | Predicted membrane proteins
| | | | | Group enriched |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC002310.13 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000455659} | Predicted intracellular proteins
| | | | | Tissue enhanced |
AC009060.2 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGRP | Agouti related neuropeptide | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMHR2 | Anti-Mullerian hormone receptor, type II | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AP000350.10 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000400325} | Predicted membrane proteins
| | | | | Tissue enhanced |
ASTN1 | Astrotactin 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AVPR1A | Arginine vasopressin receptor 1A | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C2orf66 | Chromosome 2 open reading frame 66 | Predicted secreted proteins
| | | | | Tissue enhanced |
C7 | Complement component 7 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CABP7 | Calcium binding protein 7 | Predicted membrane proteins
| | | | | Tissue enhanced |
CADPS | Ca++-dependent secretion activator | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CALN1 | Calneuron 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CBLN4 | Cerebellin 4 precursor | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CELA1 | Chymotrypsin-like elastase family, member 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CELF3 | CUGBP, Elav-like family member 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CNGB1 | Cyclic nucleotide gated channel beta 1 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |